ABBOTT LABORATORIES — Director's Dealing 2017

Dec 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-12-12

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-12	Common shares without par value	G	1440	—	Disposed	3146582	Direct
2017-12-13	Common shares without par value	G	23345	—	Disposed	3123237	Direct
2017-12-14	Common shares without par value	G	36352	—	Disposed	3086885	Direct
2017-12-15	Common shares without par value	G	455	—	Disposed	3086430	Direct
2017-12-12	Common shares without par value	G	720	—	Acquired	720	Indirect
2017-12-12	Common shares without par value	G	240	—	Acquired	9738	Indirect
2017-12-12	Common shares without par value	G	240	—	Acquired	9752	Indirect
2017-12-12	Common shares without par value	G	720	—	Disposed	0	Indirect
2017-12-12	Common shares without par value	G	240	—	Acquired	9978	Indirect
2017-12-12	Common shares without par value	G	240	—	Acquired	9992	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	31675	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 15, 2017.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.